What is NDC 85972-121?

85972-121 is the product NDC for Tofacitinib Citrate, Tofacitinib citrate 8.08 mg/1 tablet, film coated, listed with the FDA by Stellon Biotech Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.

Stellon Biotech Inc., NDC labeler code 85972. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Tofacitinib Citrate?

4 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Tofacitinib Citrate NDC 85972-121 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)85972-121Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85972-0121Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
85972-121-60	85972012160	60 TABLET, FILM COATED in 1 BOTTLE (85972-121-60)Marketed from Oct 1, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Tofacitinib Citrate
Generic name (nonproprietary): tofacitinib citrate
Active ingredients: Tofacitinib citrate — 8.08 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Stellon Biotech Inc.NDC labeler code 85972
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 218821
Marketing start: Oct 1, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Janus Kinase Inhibitors (Mechanism)
Identifiers: Product ID 85972-121_9d643ba7-2cb4-495a-b96d-3c1f2832442fSPL ID 9d643ba7-2cb4-495a-b96d-3c1f2832442f
Pharmacologic class: Janus Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485972012160 followed by a unit qualifier and the quantity

Package 85972-0121-60. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 85972-121

What is NDC 85972-121?: 85972-121 is the product NDC for Tofacitinib Citrate, Tofacitinib citrate 8.08 mg/1 tablet, film coated, listed with the FDA by Stellon Biotech Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Tofacitinib Citrate.
What is the active ingredient?: Tofacitinib citrate.
Who is the labeler?: Stellon Biotech Inc., NDC labeler code 85972. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Tofacitinib Citrate?: 4 other product NDCs are listed under this name. See all Tofacitinib Citrate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Tofacitinib Citrate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Tofacitinib Citrate	Tofacitinib citrate 16.16 mg/1	Tablet, Film coatedOral	Stellon Biotech Inc.	85972-122	85972-0122-60
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	ScieGen Pharmaceuticals, INC.	50228-567	50228-0567-1050228-0567-30
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	Radha Pharmaceuticals, Inc.	77771-567	77771-0567-30
Tofacitinib Citrate	Tofacitinib citrate 11 mg/1	Tablet, Film coated, Extended releaseOral	Padagis US LLC	0574-1811	00574-1811-30

Other NDCs under ANDA 218821

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 218821
Product	Strength	Form · route	Labeler	Product NDC
Tofacitinib Citrate	Tofacitinib citrate 16.16 mg/1	Tablet, Film coatedOral	Stellon Biotech Inc.	85972-122